Return On Equity of Skye Bioscience, Inc. from 30 Sep 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Skye Bioscience, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2013 to 30 Sep 2025.
  • Skye Bioscience, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -100%, a 167% decline year-over-year.
  • Skye Bioscience, Inc. annual Return On Equity for 2024 was -36%, a 103% decline from 2023.
  • Skye Bioscience, Inc. annual Return On Equity for 2023 was 1158%, a 46% decline from 2022.
  • Skye Bioscience, Inc. annual Return On Equity for 2022 was 2152%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -100% -63% -167% 01 Jul 2025 30 Sep 2025
Q2 2025 -69% +43% +39% 01 Apr 2025 30 Jun 2025
Q1 2025 -47% +165% +78% 01 Jan 2025 31 Mar 2025
Q4 2024 -36% -1194% -103% 01 Oct 2024 31 Dec 2024
Q3 2024 -38% -1280% -103% 01 Jul 2024 30 Sep 2024
Q2 2024 -112% -563% -125% 01 Apr 2024 30 Jun 2024
Q1 2024 -212% -972% -128% 01 Jan 2024 31 Mar 2024
Q4 2023 1158% -994% -46% 01 Oct 2023 31 Dec 2023
Q3 2023 1242% +2164% 01 Jul 2023 30 Sep 2023
Q2 2023 452% +709% 01 Apr 2023 30 Jun 2023
Q1 2023 760% +954% 01 Jan 2023 31 Mar 2023
Q4 2022 2152% +2332% 01 Oct 2022 31 Dec 2022
Q3 2022 -922% -699% -313% 01 Jul 2022 30 Sep 2022
Q2 2022 -257% +139% +35% 01 Apr 2022 30 Jun 2022
Q1 2022 -194% +1317% +87% 01 Jan 2022 31 Mar 2022
Q4 2021 -181% -1233% -117% 01 Oct 2021 31 Dec 2021
Q3 2021 -223% -258% -747% 01 Jul 2021 30 Sep 2021
Q2 2021 -396% -470% -632% 01 Apr 2021 30 Jun 2021
Q1 2021 -1511% -1327% -718% 01 Jan 2021 31 Mar 2021
Q4 2020 1053% +1060% 01 Oct 2020 31 Dec 2020
Q3 2020 34% -22% -39% 01 Jul 2020 30 Sep 2020
Q2 2020 74% +30% +69% 01 Apr 2020 30 Jun 2020
Q1 2020 -185% -351% -211% 01 Jan 2020 31 Mar 2020
Q4 2019 -8% -201% -104% 01 Oct 2019 31 Dec 2019
Q3 2019 56% -140% -71% 01 Jul 2019 30 Sep 2019
Q2 2019 44% -186% -81% 01 Apr 2019 30 Jun 2019
Q1 2019 167% -92% -36% 01 Jan 2019 31 Mar 2019
Q4 2018 193% +95% +97% 01 Oct 2018 31 Dec 2018
Q3 2018 196% +76% +63% 01 Jul 2018 30 Sep 2018
Q2 2018 230% +84% +58% 01 Apr 2018 30 Jun 2018
Q1 2018 259% +146% +128% 01 Jan 2018 31 Mar 2018
Q4 2017 98% -39% -28% 01 Oct 2017 31 Dec 2017
Q3 2017 120% -31% -21% 01 Jul 2017 30 Sep 2017
Q2 2017 146% -72% -33% 01 Apr 2017 30 Jun 2017
Q1 2017 113% -363% -76% 01 Jan 2017 31 Mar 2017
Q4 2016 137% -584% -81% 01 Oct 2016 31 Dec 2016
Q3 2016 152% -890% -85% 01 Jul 2016 30 Sep 2016
Q2 2016 218% -2304% -91% 01 Apr 2016 30 Jun 2016
Q1 2016 476% +22540% 01 Jan 2016 31 Mar 2016
Q4 2015 721% +3013% 01 Oct 2015 31 Dec 2015
Q3 2015 1042% +1591% 01 Jul 2015 30 Sep 2015
Q2 2015 2523% +3954% 01 Apr 2015 30 Jun 2015
Q1 2015 -22064% -21481% -3688% 01 Jan 2015 31 Mar 2015
Q4 2014 -2292% -28172% 01 Oct 2014 31 Dec 2014
Q3 2014 -549% -5915% -110% 01 Jul 2014 30 Sep 2014
Q2 2014 -1432% 01 Apr 2014 30 Jun 2014
Q1 2014 -582% 01 Jan 2014 31 Mar 2014
Q4 2013 25880%* 01 Nov 2013 31 Jan 2014
Q3 2013 5365% 01 Jul 2013 30 Sep 2013

Skye Bioscience, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -36% -1194% -103% 01 Jan 2024 31 Dec 2024
2023 1158% -994% -46% 01 Jan 2023 31 Dec 2023
2022 2152% +2332% 01 Jan 2022 31 Dec 2022
2021 -181% -1233% -117% 01 Jan 2021 31 Dec 2021
2020 1053% +1060% 01 Jan 2020 31 Dec 2020
2019 -8% -201% -104% 01 Jan 2019 31 Dec 2019
2018 193% +95% +97% 01 Jan 2018 31 Dec 2018
2017 98% -39% -28% 01 Jan 2017 31 Dec 2017
2016 137% -584% -81% 01 Jan 2016 31 Dec 2016
2015 721% +3013% 01 Jan 2015 31 Dec 2015
2014 -2292% -765% -50% 01 Jan 2014 31 Dec 2014
2013 -1526% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.